Multidrug resistance is a major hurdle for the success of cancer chemotherapy. The
main cause for this phenomenon is attributed to the overexpression of the efflux pump,
P-glycoprotein (P-gp). A small library of novel bioactive macrocyclic lathyrane-type
diterpene derivatives was developed to discover a selective P-gp reversal agent. In
this way, a macrocyclic diterpene was acylated with different alkanoyl and aroyl anhydrides/chlorides.
In order to explore the role of the substitution pattern on the modulation of P-gp
efflux, the anti-MDR effects of compounds were evaluated in human MDR1-gene transfected mouse lymphoma cells, through the rhodamine-123 exclusion assay.
Furthermore, some of the compounds synergistically enhanced the antiproliferative
effect of doxorubicin. The combination of these results with physicochemical descriptors
allowed inferring some structure-activity relationships. Strong correlations were
found between activity and molecular weight, accessible solvent areas or octanol/water
partition coefficient.
Acknowledgements: This study was supported by FCT, Portugal (project PTDC/QUI-QUI/099815/2008;
PhD grant SFRH/BD/72915/2010; PEst-OE/SAU/UI4013/2011).